Firoz Anwar

3.8k citations

87 papers · 2.8k indexed · 1 hit paper · h-index 25

Impact in

Complementary and alternative medicine top 0.2%
- Nigella sativa pharmacological applications
Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents

Papers in

Complementary and alternative medicine 18
- Nigella sativa pharmacological applications 6
- Medicinal Plants and Neuroprotection 6
Toxicology 7
- Bioactive Compounds and Antitumor Agents 7

Co-authors: Fahad A. Al‐Abbasi Vikas Kumar Mohd Mujeeb Aftab Ahmad Zoheir A. Damanhouri Asif Husain Abul Kalam Najmi Shah Alam Khan
Journals: Biomedicine & Pharmacotherapy (6 papers)Current Medicinal Chemistry (4 papers)Current Pharmaceutical Design (4 papers)Inflammopharmacology (3 papers)Pharmaceutical Biology (2 papers)
Partner nations: Saudi Arabia India United Arab Emirates

In The Last Decade

Firoz Anwar

78 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

A review on therapeutic potential of Nigella sativa: A miracle herb 2013 · 1.0k citations

Peers

Countries citing papers authored by Firoz Anwar

Since Specialization

Citations

This map shows the geographic impact of Firoz Anwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firoz Anwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firoz Anwar more than expected).

Fields of papers citing papers by Firoz Anwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Firoz Anwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firoz Anwar. The network helps show where Firoz Anwar may publish in the future.

Co-authors

The 25 scholars most cited alongside Firoz Anwar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Firoz Anwar Line = papers co-authored together Firoz Anwar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Metformin’s dual impact on Gut microbiota and cardiovascular health: A comprehensive analysis Biomedicine & Pharmacotherapy ·Turky Omar Asar, Fahad A. Al‐Abbasi, Ryan A. Sheikh, Mustafa Zeyadi, Muhammad Shahid Nadeem, Salma Naqvi, Vikas Kumar, Firoz Anwar	2024	4
2	Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors Current Diabetes Reviews ·Turki Mohammed M. Alqahtani, Mohammed Abdullah Alghamdi, Mirza Rafi Baig, Fahad A. Al‐Abbasi, Rizwan Shiek, (unknown), (unknown), Sultan Alhayyani, Turky Omar Asar, Vikas Kumar, Firoz Anwar	2024	2
3	In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1 Molecules ·Mohammed Kaleem, Asaad Kayali, Ryan A. Sheikh, Abudukadeer Kuerban, Mohammed Hassan, Naif A. R. Almalki, Fahad A. Al‐Abbasi, Firoz Anwar, Ziad Omran, Mahmoud Alhosin	2024	10
4	Synchronized Glioma Insights: Trends, Blood Group Correlations, Staging Dynamics, and the Vanguard of Liquid Biopsy Advancements CNS & Neurological Disorders - Drug Targets ·Ryan A. Sheikh, Salma Naqvi, (unknown), Ayman Mohammed Al-Sulami, Mohammed Bayamin, Abdullaha Samsahan, Mirza Rafi Baig, Fahad A. Al‐Abbasi, Naif A. R. Almalki, Turky Omar Asar, Firoz Anwar	2024	0
5	Scientific Writing – ChatGPT Versus Real-time Output: AddressingAcademician’s Concern Firoz Anwar, Salman Hosawi, Fahad A. Al‐Abbasi, Turky Omar Asar	2024	0
6	Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma International Journal of Nanomedicine ·Firoz Anwar, Fahad A. Al‐Abbasi, Salma Naqvi, Ryan A. Sheikh, Sultan Alhayyani, Amer H. Asseri, Turky Omar Asar, Vikas Kumar	2023	4
7	Tubulin Proteins in Cancer Resistance: A Review Current Drug Metabolism ·Mohammad Amjad Kamal, Maryam H. Al-Zahrani, Salman Hasan Khan, Mateen Hasan Khan, Hani Awad Al-Subhi, Abudukadeer Kuerban, Muhammad Aslam, Fahad A. Al‐Abbasi, Firoz Anwar	2020	25
8	Antiviral effects of probiotic metabolites on COVID-19 Journal of Biomolecular Structure and Dynamics ·Firoz Anwar, Hisham N. Altayb, Fahad A. Al‐Abbasi, Abdulrahman L. Al‐Malki, Mohammad Amjad Kamal, Vikas Kumar	2020	108
9	Biochemical and toxicological effect of diazepam in stress-induced cardiac dysfunctions Toxicology Reports ·Fahad A. Al‐Abbasi, Vikas Kumar, Firoz Anwar	2020	7
10	Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma Drug Delivery ·Mahfoozur Rahman, Shareefa A. AlGhamdi, Khalid Saad Alharbi, Sarwar Beg, Kalicharan Sharma, Firoz Anwar, Fahad A. Al‐Abbasi, Vikas Kumar	2019	64
11	Nanomedicine in treatment of breast cancer – A challenge to conventional therapy Seminars in Cancer Biology ·Muhammad Afzal, Ameeduzzafar Zafar, Khalid Saad Alharbi, Nabil K. Alruwaili, Fahad A. Al‐Abbasi, Abdulrahman A. Almalki, Imran Kazmi, Vikas Kumar, Mohammad Amjad Kamal, Muhammad Shahid Nadeem, Muhammad Aslam, Firoz Anwar	2019	94
12	Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis Inflammopharmacology ·Muhammad Afzal, D. P. Bhardwaj, Ruqaiyah Khan, Imran Kazmi, Shakir Saleem, Fahad A. Al‐Abbasi, Firoz Anwar	2018	7
13	Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway Inflammopharmacology ·Amita Verma, Deepika Singh, Firoz Anwar, Prakash Chandra Bhatt, Fahad A. Al‐Abbasi, Vikas Kumar	2017	50
14	Protective effect of oleane-12-en-3β-ol-28-oic acid 3β-D-glucopyranoside in ethanol induced gastric ulcer by enhancing the prostaglandin E2 level Journal of Ethnopharmacology ·Imran Kazmi, Shakir Saleem, Tanveer Ahmad, Muhammad Afzal, Fahad A. Al‐Abbasi, Vikas Kumar, Firoz Anwar	2017	12
15	Pharmacological and molecular activity of methanolic extract of Cichorium intybus Linn seeds European Journal of Experimental Biology ·Rizwan Ahamad, Mohd Mujeeb, Firoz Anwar, Aftab Ahmad	2015	2
16	Phytochemical analysis and evaluation of anti-oxidant activity of methanolicextract of Lepidium sativum L. seeds. Der pharmacia lettre ·Rizwan Ahamad, Mohd Mujeeb, Firoz Anwar, Aftab Ahmad	2015	9
17	Cytotoxic Activity of Sulphonamide with Selenium to Decrease Raised Lipid Profile in the Treatment Hepatocarcinogenesis Ritu Gupta, Firoz Anwar, R. L. Khosa	2014	0
18	DETECTION OF LATENT INFECTION OF PHYTOPHTHORA INFESTANS IN POTATO SEED TUBERS Potato Journal/Journal of the Indian Potato Association ·Touseef Hussain, Sanjeev Sharma, Pushpendra Singh, A. Jeevalatha, Vinay Sagar, Nitya Sharma, S. K. Kaushik, S. K. Chakrabarti, Firoz Anwar	2013	1
19	A quantitative Real Time PCR based method for the detection of Phytophthora infestans causing Late blight of potato, in infested soil Saudi Journal of Biological Sciences ·Touseef Hussain, B. P. Singh, Firoz Anwar	2013	24
20	Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum Fitoterapia ·Muhammad Afzal, Gaurav Gupta, Imran Kazmi, Mahfoozur Rahman, Obaid Afzal, Md. Jahangir Alam, Khalid Rehman Hakeem, Mohammad Pravez, Ritu Gupta, Firoz Anwar	2012	79

About Firoz Anwar

Firoz Anwar is a scholar working on Complementary and alternative medicine, Toxicology, Pharmacology, Molecular Medicine and Biological Psychiatry, having authored 87 papers that have together received 2.8k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (8 papers), Bioactive Compounds and Antitumor Agents (7 papers), Nigella sativa pharmacological applications (6 papers), Medicinal Plants and Neuroprotection (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Curcumin's Biomedical Applications (5 papers) and Graphene and Nanomaterials Applications (5 papers). The work is most often cited by research in Complementary and alternative medicine (1.0k citations), Toxicology (252 citations), Pharmacology (470 citations), Drug Discovery (4 citations) and Molecular Medicine (103 citations). Firoz Anwar has collaborated with scholars based in Saudi Arabia, India and United Arab Emirates. Frequent co-authors include Fahad A. Al‐Abbasi, Vikas Kumar, Mohd Mujeeb, Aftab Ahmad, Zoheir A. Damanhouri, Asif Husain, Abul Kalam Najmi, Shah Alam Khan, Mohammad Amjad Kamal and Imran Kazmi. Their work appears in journals such as Biomedicine & Pharmacotherapy, Current Medicinal Chemistry, Current Pharmaceutical Design, Inflammopharmacology and Pharmaceutical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact